Anxiety symptoms predict head and neck cancer survival: Exploring mediation by systemic inflammation and tumor response to treatment
- 10 July 2024
- journal article
- research article
- Published by Wiley in Psycho-Oncology
- Vol. 33 (7) , e6375
Abstract
Background: Head and neck cancers (HNC) are associated with high rates of anxiety. Anxiety has been linked to biological pathways implicated in cancer progression, though little is known about its effects on overall survival. We hypothesized that higher pretreatment anxiety levels in patients with HNC would predict poorer 2‐year overall survival and expected this relationship to be mediated by both systemic inflammation and tumor response to treatment.Methods: Patients (N = 394) reported anxiety symptomatology via the GAD‐7 at treatment planning. Pre‐treatment hematology workup provided an index of systemic inflammation (SII; N = 292). Clinical data review yielded tumor response and overall survival. Logistic and multiple regressions and Cox proportional hazard models tested hypothesized relationships.Results: Higher pretreatment anxiety levels were significantly associated with poorer 2‐year survival (hazard ratio [HR], 1.039; 95% confidence interval [CI], 1.014–1.066, p = 0.002). The association between anxiety and SII was not significant, though anxiety was associated with poorer tumor response (odds ratio [OR], 1.033; 95% CI, 1.001–1.066, p = 0.043). Tumor response fully mediated the relationship between anxiety symptoms and 2‐year survival (HR, 9.290, 95% CI, 6.152–14.031, p < 0.001).Conclusions: Anxiety was associated with overall survival. Tumor response, but not systemic inflammation, emerged as a potential biological pathway mediating this effect. Screening for anxiety may be beneficial to help prospectively address these concerns and ameliorate potentially detrimental impact on clinically meaningful cancer outcomes.Keywords
Funding Information
- National Cancer Institute (R25‐CA134283‐06A1)
- National Institutes of Health
- National Institute of General Medical Sciences (R25‐ GM148314‐01)
This publication has 30 references indexed in Scilit:
- Depressive Symptoms, Systemic Inflammation, and Survival Among Patients With Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 2024
- Screening for Anxiety Disorders in AdultsJAMA, 2023
- Depression and anxiety in colorectal cancer patients: Ties to pain, fatigue, and inflammationPsycho-Oncology, 2022
- Characteristics and outcomes associated with anxiety and depression in a head and neck cancer survivorship cohortAmerican Journal of Otolaryngology, 2022
- Prognostic significance of the preoperative systemic immune‐inflammation index in patients with oral cavity squamous cell carcinoma treated with curative surgery and adjuvant therapyCancer Medicine, 2020
- Association of age and gender with anxiety disorders in older adults: A systematic review and meta‐analysisInternational Journal of Geriatric Psychiatry, 2018
- Depressive symptoms and actigraphy‐measured circadian disruption predict head and neck cancer survivalPsycho-Oncology, 2018
- The Generalized Anxiety Disorder Screener (GAD‐7) and the anxiety module of the Hospital and Depression Scale (HADS‐A) as screening tools for generalized anxiety disorder among cancer patientsPsycho-Oncology, 2018
- Depressive symptoms predict head and neck cancer survival: Examining plausible behavioral and biological pathwaysCancer, 2018
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006